查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1760732

2025年经皮给药系统全球市场报告

Transdermal Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，经皮给药系统市场规模将强劲成长。到2029年，该市场规模将以8.0%的年复合成长率（CAGR）成长至550亿美元。预测期内的成长将受到多种因素的推动，例如患者对非侵入性治疗的偏好日益增长、慢性病患病率上升、对便捷给药方式的需求不断增长、疼痛管理应用的不断拓展以及对新型给药系统的监管支持。这段时期的主要趋势包括个人化给药的创新、奈米技术在改善吸收方面的应用、智慧型贴片的开发、皮肤渗透技术的进步、生物活性化合物的引入以及用于慢性病管理的可穿戴设备的进步。

预计慢性病盛行率的上升将在未来几年推动经皮给药系统市场的成长。糖尿病和心臟病等慢性病需要持续管理并限制日常活动。久坐不动的生活方式会导致体重增加、心血管健康不佳、代谢失衡等，加剧慢性病的发生率。经皮给药系统用于治疗此类疾病，透过皮肤持续且可控制地释放药物，提高患者的依从性并确保稳定的治疗水准。例如，2023 年 6 月，卫生指标与评估研究所报告称，全球有超过 5 亿人患有糖尿病，预计到 2050 年这一数字将翻一番，达到 13 亿。因此，慢性病的流行正在推动经皮给药系统市场的扩张。

经皮给药系统市场的主要企业正专注于微针技术等技术进步，以改善药物吸收和患者依从性。微针是一种微创装置，可无痛地经皮输送药物，为传统注射提供了创伤较小的替代方案。例如，2024年10月，韩国大熊製药有限公司推出了其微针平台CLOPAM。该平台显着提高了药物输送效率，最大限度地减少了注射的不适，并实现了药物的可控和持续释放。其目标是提供一种无痛且持续的口服或註射治疗治疗方法，从而提高患者的依从性和治疗效果。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球经皮给药系统 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球经皮给药系统市场：成长率分析
  • 全球经皮给药系统市场表现：规模与成长，2019-2024
  • 全球经皮给药系统市场预测：规模与成长，2024-2029年，2034年
  • 经皮的全球总目标市场（TAM）

第六章市场区隔

  • 全球经皮给药系统市场（依製剂类型、效能及预测），2019-2024 年、2024-2029 年、2034 年
  • 药物贴片
  • 储存类型
  • 矩阵类型
  • 微型储层型
  • 全球经皮给药系统市场（依技术、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 离子电渗
  • 微操作
  • 全球经皮给药系统市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 疼痛管理
  • 中枢神经系统
  • 心血管疾病
  • 禁止抽烟
  • 全球经皮给药系统市场：依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 家庭医疗保健
  • 製药公司
  • 研究机构
  • 全球经皮给药系统市场，依药物贴片类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单层药物黏合剂
  • 多层药物黏合剂
  • 全球经皮给药系统市场储存类型细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 凝胶储液系统
  • 液体储存系统
  • 固体储存系统
  • 全球经皮给药系统市场，依基质类型细分，依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基质系统
  • 脂质基质系统
  • 水凝胶基质系统
  • 全球经皮给药系统市场，按微储库类型细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 微针阵列
  • 微乳液储层
  • 奈米颗粒输注容器

第七章 区域和国家分析

  • 全球经皮给药系统市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球经皮给药系统市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 经皮给药系统市场：竞争格局
  • 经皮给药系统市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • GSK plc
  • 3M Company
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim GmbH
  • Mylan NV
  • UCB SA
  • Skyepharma
  • Noven Pharmaceuticals Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • Watson Pharmaceuticals Inc.
  • Endo International plc
  • Transdermal Technologies Inc.
  • Grunenthal GmbH
  • 4P Therapeutics LLC
  • Actavis Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年经皮给药系统市场：提供新机会的国家
  • 2029年经皮给药系统市场：细分领域带来新机会
  • 2029年经皮给药系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35609

Transdermal drug delivery systems are methods used to administer medication through the skin, allowing for a controlled, continuous release of the drug into the bloodstream over a period of time. These systems are typically in the form of a patch or similar device applied to the skin, which gradually releases the medication, offering benefits such as avoiding the digestive system and ensuring stable drug levels in the body.

The main types of formulations for transdermal drug delivery systems include drug-in-patch, reservoir, matrix, and microreservoir types. The drug-in-patch formulation is especially common in the consumer health market due to its convenience, making it ideal for treatments such as nicotine replacement and hormone therapy. Key technologies used in transdermal drug delivery include iontophoresis and microporation. These systems are applied in various fields, including pain management, central nervous system disorders, cardiovascular diseases, and smoking cessation, and are used in settings such as hospitals, home healthcare, pharmaceutical companies, and research institutions.

The transdermal drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides transdermal drug delivery systems market statistics, including the transdermal drug delivery systems industry global market size, regional shares, competitors with the transdermal drug delivery systems market share, detailed transdermal drug delivery systems market segments, market trends, and opportunities, and any further data you may need to thrive in the transdermal drug delivery systems industry. This transdermal drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transdermal drug delivery systems market size has grown strongly in recent years. It will grow from $37.30 billion in 2024 to $40.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be attributed to factors such as an increased demand for non-invasive drug delivery, better patient adherence to treatments, enhanced bioavailability, a rise in chronic disease prevalence, and a growing preference for self-administration.

The transdermal drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $55.00 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The projected growth in the forecast period is driven by factors including a greater patient preference for non-invasive treatments, the rising prevalence of chronic diseases, an increasing demand for convenient drug delivery options, expanded uses in pain management, and regulatory support for new drug delivery systems. Key trends during this period include innovations in personalized drug delivery, the use of nanotechnology for improved absorption, the development of smart patches, advancements in skin penetration techniques, the incorporation of bioactive compounds, and breakthroughs in wearable devices for managing chronic conditions.

The increasing prevalence of chronic diseases is expected to drive the growth of the transdermal drug delivery systems market in the future. Chronic diseases, such as diabetes and heart disease, require ongoing management and limit daily activities. Factors such as sedentary lifestyles, which lead to weight gain, poor cardiovascular health, and metabolic imbalances, contribute to the rise in chronic conditions. Transdermal drug delivery systems are used in these diseases to provide a continuous, controlled release of medication through the skin, improving patient adherence and ensuring stable therapeutic levels. For example, in June 2023, the Institute for Health Metrics and Evaluation reported that over half a billion people worldwide were living with diabetes, with this number expected to double, reaching 1.3 billion by 2050. Thus, the growing prevalence of chronic diseases is driving the market expansion for transdermal drug delivery systems.

Key players in the transdermal drug delivery systems market are concentrating on technological advancements such as microneedle technology to improve drug absorption and patient compliance. Microneedles are minimally invasive devices that deliver drugs through the skin painlessly, offering a less invasive alternative to traditional injections. For example, in October 2024, Daewoong Pharmaceutical Co. Ltd., a South Korea-based company, launched its microneedle platform CLOPAM. This platform significantly enhances drug delivery efficiency, minimizes the discomfort associated with injections, and provides controlled, sustained medication release. The goal is to offer a painless and consistent alternative to oral or injectable treatments, thereby improving patient compliance and treatment effectiveness.

In August 2022, LTS Lohmann Therapie-Systeme AG, a pharmaceutical company based in Germany, acquired Tapemark Inc. for an undisclosed amount. This acquisition strengthens LTS's drug delivery capabilities, expanding its expertise in production and bolstering its position in the field of transdermal and advanced drug delivery solutions. Tapemark Inc., based in the US, specializes in the manufacturing of transdermal drug delivery systems.

Major players in the transdermal drug delivery systems market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, 3M Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan NV, UCB S.A., Skyepharma, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies, Inc., Grunenthal GmbH, 4P Therapeutics LLC, and Actavis Inc.

North America was the largest region in the transdermal drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transdermal drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transdermal drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transdermal drug delivery systems market consists of sales of gels, creams, and microneedles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the defined geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transdermal drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transdermal drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Formulation Type: Drug-In-Patch; Reservoir Type; Matrix Type; Microreservoir Type
  • 2) By Technology: Iontophoresis; Microporation
  • 3) By Application: Pain Management; Central Nervous System; Cardiovascular Diseases; Smoking Cessation
  • 4) By End User: Hospitals; Home Healthcare; Pharmaceutical Companies; Research Institutes
  • Subsegments:
  • 1) By Drug-In-Patch: Single-layer Drug-in-Adhesive; Multi-layer Drug-in-Adhesive
  • 2) By Reservoir Type: Gel Reservoir Systems; Liquid Reservoir Systems; Solid Reservoir Systems
  • 3) By Matrix Type: Polymer Matrix Systems; Lipid Matrix Systems; Hydrogel Matrix Systems
  • 4) By Microreservoir Type: Microneedle Arrays; Microemulsion Reservoirs; Nanoparticle-Infused Reservoirs
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transdermal Drug Delivery Systems Market Characteristics

3. Transdermal Drug Delivery Systems Market Trends And Strategies

4. Transdermal Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Transdermal Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transdermal Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transdermal Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Transdermal Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transdermal Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transdermal Drug Delivery Systems Total Addressable Market (TAM)

6. Transdermal Drug Delivery Systems Market Segmentation

  • 6.1. Global Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-In-Patch
  • Reservoir Type
  • Matrix Type
  • Microreservoir Type
  • 6.2. Global Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iontophoresis
  • Microoperation
  • 6.3. Global Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Central Nervous System
  • Cardiovascular Diseases
  • Smoking Cessation
  • 6.4. Global Transdermal Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Home Healthcare
  • Pharmaceutical Companies
  • Research Institutes
  • 6.5. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Drug-In-Patch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • 6.6. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Reservoir Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gel Reservoir Systems
  • Liquid Reservoir Systems
  • Solid Reservoir Systems
  • 6.7. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Matrix Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer Matrix Systems
  • Lipid Matrix Systems
  • Hydrogel Matrix Systems
  • 6.8. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Microreservoir Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microneedle Arrays
  • Microemulsion Reservoirs
  • Nanoparticle-Infused Reservoirs

7. Transdermal Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Transdermal Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transdermal Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transdermal Drug Delivery Systems Market

  • 8.1. Asia-Pacific Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transdermal Drug Delivery Systems Market

  • 9.1. China Transdermal Drug Delivery Systems Market Overview
  • 9.2. China Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transdermal Drug Delivery Systems Market

  • 10.1. India Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transdermal Drug Delivery Systems Market

  • 11.1. Japan Transdermal Drug Delivery Systems Market Overview
  • 11.2. Japan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transdermal Drug Delivery Systems Market

  • 12.1. Australia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transdermal Drug Delivery Systems Market

  • 13.1. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transdermal Drug Delivery Systems Market

  • 14.1. South Korea Transdermal Drug Delivery Systems Market Overview
  • 14.2. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transdermal Drug Delivery Systems Market

  • 15.1. Western Europe Transdermal Drug Delivery Systems Market Overview
  • 15.2. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transdermal Drug Delivery Systems Market

  • 16.1. UK Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transdermal Drug Delivery Systems Market

  • 17.1. Germany Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transdermal Drug Delivery Systems Market

  • 18.1. France Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transdermal Drug Delivery Systems Market

  • 19.1. Italy Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transdermal Drug Delivery Systems Market

  • 20.1. Spain Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transdermal Drug Delivery Systems Market

  • 21.1. Eastern Europe Transdermal Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transdermal Drug Delivery Systems Market

  • 22.1. Russia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transdermal Drug Delivery Systems Market

  • 23.1. North America Transdermal Drug Delivery Systems Market Overview
  • 23.2. North America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transdermal Drug Delivery Systems Market

  • 24.1. USA Transdermal Drug Delivery Systems Market Overview
  • 24.2. USA Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transdermal Drug Delivery Systems Market

  • 25.1. Canada Transdermal Drug Delivery Systems Market Overview
  • 25.2. Canada Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transdermal Drug Delivery Systems Market

  • 26.1. South America Transdermal Drug Delivery Systems Market Overview
  • 26.2. South America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transdermal Drug Delivery Systems Market

  • 27.1. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transdermal Drug Delivery Systems Market

  • 28.1. Middle East Transdermal Drug Delivery Systems Market Overview
  • 28.2. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transdermal Drug Delivery Systems Market

  • 29.1. Africa Transdermal Drug Delivery Systems Market Overview
  • 29.2. Africa Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transdermal Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Transdermal Drug Delivery Systems Market Competitive Landscape
  • 30.2. Transdermal Drug Delivery Systems Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Transdermal Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. GSK plc
  • 31.2. 3M Company
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. Boehringer Ingelheim GmbH
  • 31.5. Mylan NV
  • 31.6. UCB S.A.
  • 31.7. Skyepharma
  • 31.8. Noven Pharmaceuticals Inc.
  • 31.9. Hisamitsu Pharmaceutical Co. Inc.
  • 31.10. Watson Pharmaceuticals Inc.
  • 31.11. Endo International plc
  • 31.12. Transdermal Technologies Inc.
  • 31.13. Grunenthal GmbH
  • 31.14. 4P Therapeutics LLC
  • 31.15. Actavis Inc.

32. Global Transdermal Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transdermal Drug Delivery Systems Market

34. Recent Developments In The Transdermal Drug Delivery Systems Market

35. Transdermal Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Transdermal Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transdermal Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transdermal Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer